Who Is The MedTech Solutions Group?
MedTech Solutions Group (MTSG) was founded by 3 MedTech Executives with over 75 years in combined experience and success in globally commercializing medical devices that improved patient outcomes, lowered costs of care, and in several cases, changed the way healthcare is practiced.
• Define your international commercialization objectives.
• Develop your international marketing, sales, and clinical strategies.
• Execute and manage your international commercialization plan for existing brands or new technologies at a country level.
• Through a network of professional Distributor Partners, who know their markets and have a history of growing product portfolios.
• Led by the Regional MTSG Leadership Team Members who work with their distributor partners to grow MTSG managed brands.
• Supported by HQ MTSG Leadership Team Members who manage the overall execution of the commercialization plan for each client.Read more
Because when MTSG represents your brand, and the distributor network markets your brand, your brand receives the collective knowledge, experience, and successful track record of launching new products and growing existing brands, including:
• VAC® Therapy & SNaP®
• PROMOGRAN™ & Regranex®
• Triadyne® & Atmosair®
• Cobe® BRAT & Novacor® LVAS
• And More...
OUR Global Leadership Team
Founder, Chairman Of The Board
Past President, CEO, and Board Member of Spiracur, the developer of the first disposable, single patient use NPWT system. Vice Chairman of KCI USA where he led the launch of the VAC Therapy System, and in between, Executive Chairman of Systagenix. Chris continues to be a member of several Boards including NanoVibronix, Argentum Medical, Rochal Industries, The Wound Healing Foundation and, The World and Craniofacial Foundation.
Founder, Chief Operating Officer
Past VP of Marketing for KCI during the launch of VAC Therapy, and later, for Spiracur, developing the acute strategy for their disposable NPWT system. Global experience in executive management, marketing strategy, product development, and QC/QA. Held positions of increasing responsibility for start-up (Cupron Medical, Novacor) to industry leading (KCI, Baxter, Cobe) companies operating in the wound care, pulmonary, cardiovascular, intensive care, and infection mgmt. markets.
Founder, Chief Clinical Officer
Certified emergency, critical care, and burn nurse (active duty USAF, US Army Institute of Surgical Research). Responsible for clinical education and sales training during the launch of KCI and Spiracur NPWT offerings. Clinically focused, global, industry experience (Spiracur, KCI, Hollister, Inotec, Kerecis) including research, product development/launch, clinical education, sales training, and reimbursement.
Director, Clinical Services
Over 17 years of experience as a clinical practitioner with a primary focus on advanced wound and ostomy care. She possesses a Bachelor of Science in Nursing and a Master of Science in Nursing Leadership and Management. She is a Full-Scope Wound/Ostomy/Continence Nurse Specialist and participates in several professional wound care organizations.
Office Manager & Executive Assistant
Experienced executive assistant and office management professional who has supported senior executives in the administrative, legal, and wound care businesses. Prior to MTSG, Debbie has worked with Chris and other members of the MTSG team at KCI, Systagenix, and Atteris.
VP Business Development
Over 25 years experience establishing and leading international commercialization strategies and organizations for multiple medical device companies, including KCI, Systagenix, and Spiracur. Based in London, England
VP & General Manager
Europe, Middle East, Africa
Over 30 years experience in the wound care industry, most recently as the Worldwide Head of Wound Care for Convatec, based in Switzerland. Paul has also held leadership roles within the wound care franchises of BSN Medical, KCI, and Smith and Nephew; as well as leading an award-winning start-up in the wound management space. Based in London, England
VP & General Manager
Over 20 years experience representing PolyMem and other products in the wound care space initially as an owner of a distribution company in Australia and for the last 14 years as the Regional Director for Asia Pacific. Based In Brisbane, Australia
VP & General Manager
Over 20 years experience in the development of the Latin America market for select medical products including KCI’s VAC Therapy Independent owner of distributor company in Latin America. Based in Mexico City, Mexico
Need a one-stop solution for your International commercialization needs?
Think Globally…Execute Locally
The MedTech Solutions Group provides a one-stop solution for your international medical device commercialization needs.
We partner with our clients to 1) define their international commercialization objectives; 2) develop their international marketing, sales, and clinical strategies; and 3) execute and manage their international commercialization plan for existing brands or new technologies at a country level.
Country level execution and management is led by the regional based members of the MTSG Leadership Team, supported by a team of clinical specialists, and delivered to end user customers through a network of distributors to 75+ countries.
In addition to launching VAC Therapy in
1995 and establishing the Negative Pressure
Wound Therapy (NPWT) Category into what is
today a $2B global market, the MTSG team played
a significant role in bringing innovation to other
important Therapeutic Categories
1 Stop Solution
MTSG provides a one-stop solution for your
International medical device commercialization
Launching Products, Growing Brands
We are uniquely experienced in combining global strategic thinking and planning, with regional leadership, execution, and support.
MTSG Team members, working individually and together, have a proven history of global success in launching new products and technologies, as well as growing existing brands. Our success has been achieved with multiple disposable and capital equipment technologies and brands, across several therapeutic categories.
Every client who partners with the MedTech Solutions Group to address their International commercialization needs receives the benefits identified in our Core Strengths below.